Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Serono Expand Proteomics Deal

NEW YORK, Jan. 28-Inpharmatica and Serono are expanding their proteomics  collaboration, the two companies said this morning.


The two firms struck a collaboration in mid-2001 in which Inpharmatica supplies Serono with protein sequences to aid in drug and drug target discovery.


This agreement expands the deal, so that Inpharmatica will provide additional proprietary genomic sequence data from other protein families.


Inpharmatica will receive milestone and royalty payments based on any products developed, as well as additional research funding.


Inpharmatica, based in London, uses informatics and a large compute farm to analyze protein data for drug discovery.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.